MSTN and chronic obstructive pulmonary disease: Quantitative analyses revealed that the relative levels of myostatin in the GN tissues from the rats that had been treated with Salidroside at a medium or high dose were comparable with that in the healthy group, but significantly lower than that in the COPD group (P<0.001 for all, Figure 4B).